Borgia G - Search Results

1

Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy.

Gentile I, Buonomo AR, Maraolo AE, Scotto R, De Zottis F, Di Renzo G, Borgia G. Gentile I, et al. Among authors: borgia g. J Antimicrob Chemother. 2017 Sep 1;72(9):2678-2679. doi: 10.1093/jac/dkx172. J Antimicrob Chemother. 2017. PMID: 28575437 No abstract available.

2

What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?

Gentile I, Maraolo AE, Borgia G. Gentile I, et al. Among authors: borgia g. Expert Rev Anti Infect Ther. 2016 Oct;14(10):875-8. doi: 10.1080/14787210.2016.1233060. Expert Rev Anti Infect Ther. 2016. PMID: 27599088 No abstract available.

3

Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art.

Maraolo AE, Cascella M, Corcione S, Cuomo A, Nappa S, Borgia G, De Rosa FG, Gentile I. Maraolo AE, et al. Among authors: borgia g. Expert Rev Anti Infect Ther. 2017 Sep;15(9):861-871. doi: 10.1080/14787210.2017.1367666. Epub 2017 Aug 18. Expert Rev Anti Infect Ther. 2017. PMID: 28803496 Review.

4

Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.

Gentile I, Coppola N, Buonomo AR, Zappulo E, Borgia G. Gentile I, et al. Among authors: borgia g. Expert Opin Investig Drugs. 2014 Sep;23(9):1211-23. doi: 10.1517/13543784.2014.921680. Epub 2014 May 21. Expert Opin Investig Drugs. 2014. PMID: 24848437 Review.

5

Dasabuvir: A Non-Nucleoside Inhibitor of NS5B for the Treatment of Hepatitis C Virus Infection.

Gentile I, Buonomo AR, Borgia G. Gentile I, et al. Among authors: borgia g. Rev Recent Clin Trials. 2014;9(2):115-23. doi: 10.2174/1574887109666140529222602. Rev Recent Clin Trials. 2014. PMID: 24882169 Review.

6

ABT-450: a novel protease inhibitor for the treatment of hepatitis C virus infection.

Gentile I, Borgia F, Buonomo AR, Zappulo E, Castaldo G, Borgia G. Gentile I, et al. Among authors: borgia g, borgia f. Curr Med Chem. 2014;21(28):3261-70. doi: 10.2174/0929867321666140706125950. Curr Med Chem. 2014. PMID: 25005190 Review.

7

Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment.

Gentile I, Borgia G. Gentile I, et al. Among authors: borgia g. Evid Based Med. 2014 Dec;19(6):223-4. doi: 10.1136/ebmed-2014-110051. Epub 2014 Jul 15. Evid Based Med. 2014. PMID: 25028605 No abstract available.

8

Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection.

Gentile I, Buonomo AR, Borgia G. Gentile I, et al. Among authors: borgia g. Expert Rev Anti Infect Ther. 2014 Sep;12(9):1033-43. doi: 10.1586/14787210.2014.940898. Epub 2014 Jul 30. Expert Rev Anti Infect Ther. 2014. PMID: 25074011 Review.

9

A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital.

Gentile I, Landolfo D, Buonomo AR, Crispo M, Iula VD, Minei G, Catania MR, Borgia G. Gentile I, et al. Among authors: borgia g. Infez Med. 2015 Mar;23(1):12-7. Infez Med. 2015. PMID: 25819045 Free article.

10

A pill a day keeps HCV away.

Gentile I, Borgia G. Gentile I, et al. Among authors: borgia g. Lancet Infect Dis. 2015 Jun;15(6):616-7. doi: 10.1016/S1473-3099(15)70127-1. Epub 2015 Apr 8. Lancet Infect Dis. 2015. PMID: 25863561 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters